Fibromyalgia is one of the most challenging chronic pain conditions, impacting millions worldwide. Traditional treatments often fall short, leaving both patients and providers searching for better solutions. Enter the session “An Emerging Gold Standard Treatment for Patients with Fibromyalgia: Early Insights from Mayo Clinic’s Behavioral Health Program,” presented by Drs. Arya Mohabbat and Kim Fischer at PainConnect.
What to Expect
This session sheds light on Mayo Clinic’s ongoing randomized controlled trial (RCT) exploring behavioral health interventions integrated with traditional fibromyalgia care. The innovative approach combines standard treatments with virtual, asynchronous, and longitudinal pain coaching to improve outcomes and access for patients. Attendees will learn how this strategy could revolutionize fibromyalgia care through:
- Targeted Interventions: Identifying fibromyalgia patients who can benefit most from behavioral health approaches.
- Evidence-Based Practices: Adapting treatments based on new RCT insights measuring pain severity, quality of life, and more.
- Holistic Care Models: Alleviating value-based care pressures with a patient-centered, behavioral health-centric strategy.
Why It Matters
Preliminary research indicates that integrating non-pharmacological, tech-enabled behavioral health interventions leads to significant improvements in patient outcomes, including reduced pain severity and enhanced quality of life. As fibromyalgia care continues to evolve, this session offers actionable knowledge for clinicians to bridge the gap between current practices and optimal care strategies.
Don’t miss this opportunity to explore cutting-edge research that promises to redefine treatment for fibromyalgia. Attend this session to gain early insights into a potentially game-changing approach for chronic pain management.
Secure your spot at PainConnect, the AAPM annual meeting today—be part of the conversation shaping the future of pain care!
